The Treatment of Primary and Metastatic Hepatic Neoplasms Using Percutaneous Cryotherapy

ABSTRACT

Cryotherapy has been used clinically in the treatment of metastatic liver malignancies since the 1980s. Rapid freezing to sub-zero temperatures promotes ice formation in the extracellular space and the exit of intracellular water. Cellular death is the result of dehydration, protein denaturation, and microcirculatory failure. Cryotherapy probes use nitrogen or argon gas as a coolant and the development of the ice ball can be monitored using ultrasound, computed tomography, or magnetic resonance imaging. Traditionally, cryotherapy has been performed during laparoscopy or laparotomy, using intraoperative ultrasound for image guidance. A decrease in cryoprobe size (from ~24 Fr to ~15 gauge) in conjunction with experience gained in open cryosurgical treatment has allowed the development of minimally invasive percutaneous approaches. In this review, we describe the use of cryotherapy for treatment of primary or secondary liver neoplasms using a percutaneous approach.

Liver malignancy - ablation - cryotherapy

REFERENCES

• 1 Staley C A. Surgical therapy of hepatic tumors. In: Zakim D, Boyer TD Hepatology: A Textbook of Liver Disease. Philadelphia; Saunders 2003: 1371-1381
• 2 Scheele J. Hepatectomy for liver metastases.  Br J Surg. 1993;  80 274-276
• 3 Gilbert H A, Kagan A R. Metastases: incidence, detection and evaluation without histologic confirmation. In: Weiss L Fundamental Aspects of Metastases. Amsterdam; North Holland Publishing 1976: 385-405
• 4 Geoghegan J G, Scheele J. Treatment of colorectal liver metastasis.  Br J Surg. 1999;  86 158-169
• 5 Allen-Mersh T G, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.  Lancet. 1994;  344 1255-1260
• 6 Goldberg S N, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma.  J Clin Gastroenterol. 2002;  35 S115-S129
• 7 Ravikumar T S, Steele Jr G D. Hepatic cryosurgery.  Surg Clin North Am. 1989;  69 433-440
• 8 McCarthy T, Kuhn J A. Cryotherapy for liver tumors.  Oncology. 1998;  12 979-993
• 9 Cuschieri A, Crosthwaite G, Shimi S et al.. Hepatic cryotherapy for liver tumors: development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use.  Surg Endosc. 1995;  9 483-489
• 10 Adam R, Majno P, Castaing D et al.. Treatment of irresectable liver tumors by percutaneous cryosurgery.  Br J Surg. 1998;  85 1493-1494
• 11 Frezza E E. Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses.  Dig Dis Sci. 2004;  49 866-871
• 12 Farmer D G, Rosove M H, Shaked A et al.. Current treatment modalities for HCC.  Ann Surg. 1994;  219 236-247
• 13 Zibari G B, Riche A, Zizzi H C et al.. Surgical and non-surgical management of primary and metastatic liver tumors.  Am Surg. 1998;  64 211-220
• 14 Nagasue N, Yukay H, Ogawa Y et al.. Clinical experience with 118 hepatic resections for HCC.  Surgery. 1986;  99 694-701
• 15 Wu M, Chen H, Yao X. Surgical treatment of primary liver cancer.  Zhonghua Wai Ke Za Zhi. 1996;  34 707-710
• 16 Moreno Gonzalez E, Gomez R, Garcia I et al.. Liver transplantation in malignant hepatic neoplasms.  Am J Surg. 1992;  163 395-400
• 17 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for the treatment of small HCC in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
• 18 Pichlmayr R, Weimann A, Oldhafer K J et al.. Role of liver transplantation in the treatment of unresectable liver cancer.  World J Surg. 1995;  19 807-813
• 19 Selby R, Kadry Z, Carr B et al.. Liver transplantation for HCC.  World J Surg. 1995;  19 53-58
• 20 Gugenheim J, Baldini E, Casaccia M et al.. Hepatic resection and transplantation for HCC in patients with cirrhosis.  Gastroenterol Clin Biol. 1997;  21 590-595
• 21 Geoghegan J G, Scheele J. Treatment of colorectal liver metastases.  Br J Surg. 1999;  86 158-169
• 22 Holbrook R F, Koo K, Ryan J A. Resection of malignant primary liver tumors.  Am J Surg. 1996;  171 453-455
• 23 Huscher C GS, Lirici M M, Crafa F, Corradi A, Recher A. The technique of laparoscopic liver resection. 7th World Congress of Endoscopic Surgery. Singapore; 2000: 497-506
• 24 Nerenstone S R, Ihde D C, Friedman M A. Clinical trials in primary hepatocellular carcinoma: current status and future directions.  Cancer Treat Rev. 1988;  15 1-31
• 25 Colleoni M, Gaion F, Liessi G et al.. Medical treatment of hepatocellular carcinoma: any progress?.  Tumori. 1994;  80 315-326
• 26 Falkson G, Moertel C, Lavin P et al.. Chemotherapy studies in primary liver cancer: a prospective randomised clinical trial.  Cancer. 1978;  42 2149-2156
• 27 Brennan M, Taley R, San Diego E et al.. Critical analysis of 594 cancer patients treated with 5-FU. In: Platner A Proceedings of the International Symposium on Chemotherapy of Cancer. New York; Elsevier 1964: 118-119
• 28 Chlebowski R, Brzechwa-Adjukiewicz A, Cowden A et al.. Doxorubicin for HCC: clinical and pharmacokinetic results.  Cancer Treat Rep. 1984;  68 487-491
• 29 Lai C L, Wu P C, Chan G CB et al.. Doxorubicin versus no anti-tumor therapy in inoperable HCC: a prospective randomised trial.  Cancer. 1988;  62 479-483
• 30 Broder L E, Carter S K. Pancreatic islet cell carcinoma: results of therapy with streptozotocin in 52 patients.  Ann Intern Med. 1973;  79 108-118
• 31 Kessinger A, Foley J F, Lemon H M. Therapy of malignant APUD cell tumors: effectiveness of DTIC.  Cancer. 1983;  51 790-794
• 32 Moertel C G, Johnson C M, McKusick M A et al.. The management of patients with advanced carcinoid tumors and islet cell carcinomas.  Ann Intern Med. 1994;  120 302-309
• 33 Folprecht G, Grothey A, Alberts S, Raab H R, Kohne C H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.  Ann Oncol. 2005;  16 1311-1319
• 34 Cunningham D, Humblet Y, Siena S et al.. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.  N Engl J Med. 2004;  351 337-345
• 35 Hurwitz H, Fehrenbacher L, Novotny W et al.. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  350 2335-2342
• 36 McGahan J P, Browning P D, Brock J M, Teslik H. Hepatic ablation using radiofrequency electrocautery.  Invest Radiol. 1990;  25 267-270
• 37 Rossi P. Radiofrequency ablation of the liver tumours. Paper presented at International Symposium on Endovascular Therapy. Miami Beach, FL; January 23-27, 1999
• 38 Curley S A, Davidson B S, Fleming R Y et al.. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver.  Surg Endosc. 1997;  11 729-733
• 39 Solbiati L, Ierace T, Goldberg S N et al.. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.  Radiology. 1997;  202 195-203
• 40 Livraghi T, Goldberg S N, Monti F et al.. Saline enhanced radiofrequency tissue ablation in the treatment of liver metastases.  Radiology. 1997;  202 205-210
• 41 Curley S A, Izzo F, Delrio P et al.. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.  Ann Surg. 1999;  230 1-8
• 42 Jiao L R, Hansen P D, Havlik R, Mitry R R, Pignatelli M, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.  Am J Surg. 1999;  177 303-306
• 43 Lencioni R, Goletti O, Armillotta N et al.. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial.  Eur Radiol. 1998;  8 1205-1211
• 44 Marone G, Francica G, D'Angelo V et al.. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle].  Radiol Med (Torino). 1998;  95 624-629
• 45 Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a cooled tip needle: a preliminary clinical experience.  Eur J Ultrasound. 1999;  9 145-153
• 46 Kainuma O, Asano T, Aoyama H et al.. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer.  Hepatogastroenterology. 1999;  46 1071-1077
• 47 Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.  Ultraschall Med. 1999;  20 47-53
• 48 Holtkamp W, Muller W. [Ultrasonically controlled percutaneous high frequency thermotherapy of liver tumours with perfused needle electrodes].  Z Gastroenterol. 2000;  38 221-227
• 49 Livraghi T, Goldberg S N, Lazzaroni S et al.. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions.  Radiology. 2000;  214 761-768
• 50 Tranberg K G. Percutaneous ablation of liver tumours.  Best Pract Res Clin Gastroenterol. 2004;  18 125-145
• 51 Mulier S, Mulier P, Ni Y et al.. Complications of radiofrequency coagulation of liver tumours.  Br J Surg. 2002;  89 1206-1222
• 52 Adam A. Interventional radiology in the treatment of hepatic metastases.  Cancer Treat Rev. 2002;  28 93-99
• 53 Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.  Clin Liver Dis. 2005;  9 301-314
• 54 Livraghi T, Goldberg S N, Lazzaroni S et al.. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection.  Radiology. 1999;  210 655-661
• 55 Xu K C, Niu L Z, He W B, Guo Z Q, Hu Y Z, Zuo J S. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma.  World J Gastroenterol. 2003;  9 2686-2689
• 56 Koda M, Murawaki Y, Mitsuda A et al.. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.  Cancer. 2001;  92 1516-1524
• 57 Copper I S. Cryogenic surgery: a new method of destruction of extirpation of benign or malignant tissues.  N Engl J Med. 1963;  268 743-749
• 58 Ravikumar T S, Steele Jr G D. Hepatic cryosurgery.  Surg Clin North Am. 1989;  69 433-440
• 59 Seifert J K, Morris D L. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer.  Br J Surg. 1999;  86 234-240
• 60 Ross W B, Horton M, Bertolino P, Morris D L. Cryotherapy of liver tumours: a practical guide.  HPB Surg. 1995;  8 167-173
• 61 Silverman S G, Sun M RM, Tuncali K et al.. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases.  AJR Am J Roentgenol. 2004;  183 707-712
• 62 Kuszyk B S, Choti M A, Urban B A et al.. Hepatic tumors treated by cryosurgery: normal CT appearance.  AJR Am J Roentgenol. 1996;  166 363-368
• 63 Silverman S G, Collick B D, Figueira M R et al.. Interactive MR-guided biopsy in an open-configuration MR imaging system.  Radiology. 1995;  197 175-181
• 64 Zhou X D, Tang Z Y, Yu Y Q et al.. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases.  J Cancer Res Clin Oncol. 1993;  120 100-102
• 65 Huang A, McCall J M, Weston M D et al.. Phase I study of percutaneous cryotherapy for colorectal liver metastasis.  Br J Surg. 2002;  89 303-310
• 66 Seifert J K, Junginger T h. Prognostic factors for cryotherapy of colorectal liver metastases.  Eur J Surg Oncol. 2004;  30 34-40
• 67 Rosen C B, Nagorney D M, Taswell H F et al.. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma.  Ann Surg. 1992;  216 493-505
• 68 Seifert J K, Morris D L. World survey on the complications of hepatic and prostate cryotherapy.  World J Surg. 1999;  23 109-114
• 69 Ng K K, Lam C M, Poon R T et al.. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model.  Ann Surg Oncol. 2004;  11 650-657
• 70 Crews K A, Kuhn J A, McCarty T M et al.. Cryosurgical ablation of hepatic tumors.  Am J Surg. 1997;  174 614-617
• 71 Adam R, Akpinar E, Johann M et al.. Place of cryosurgery in the treatment of malignant liver tumors.  Ann Surg. 1997;  225 39-48
• 72 Zhou X D, Tang Z Y. Management of hepatocellular carcinoma: longterm outcome in 2639 cases.  Gan To Kagaku Ryoho. 1997;  24 9-16
• 73 Zhou X D, Tang Z Y, Yu Y Q et al.. Clinical evaluation of cryosurgery in the treatment of primary liver cancer: report of 60 cases.  Cancer. 1988;  61 1889-1892
• 74 Wong W S, Patel S C, Cruz F S et al.. Cryosurgery as a treatment for advanced-stage hepatocellular carcinoma: results, complications, and alcohol ablation.  Cancer. 1998;  82 1268-1278
• 75 Cha C, Lee F T, Rikkers L F et al.. Rationale for the combination of cryoablation with surgical resection of hepatic tumors.  J Gastrointest Surg. 2001;  5 206-213
• 76 Bilchik A J, Wood T F, Allefra D P et al.. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms.  Arch Surg. 2000;  135 657-664
• 77 Seifert J K, Morris D L. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer.  Ann Surg. 1998;  228 201-208
• 78 Mala T, Edwin B, Mathisen O et al.. Cryoablation of colorectal liver metastases: minimally invasive tumour control.  Scand J Gastroenterol. 2004;  39 571-578
• 79 Cozzi P J, Englund R, Morris D L. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors.  Cancer. 1995;  76 501-509
• 80 Seifert J K, Cozzi P J, Morris D L. Cryotherapy for neuroendocrine liver metastases.  Semin Surg Oncol. 1998;  14 175-183
• 81 Shapiro R S, Shafir M, Sung M, Warner R, Glajchen N. Cryotherapy of metastatic carcinoid tumors.  Abdom Imaging. 1998;  23 314-317